BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1

about

BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1

Item

http://www.wikidata.org/entity/Q58712577

description

scientific article published on 20 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@en

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@nl

type

Item

label

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@en

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@nl

prefLabel

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@en

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@nl

P1476

BRAF inhibition causes resilie ...... inducing the secretion of FGF1

@en

P2093

Andreas Borst

http://www.w3.org/2001/XMLSchema#string

Anita Hufnagel

http://www.w3.org/2001/XMLSchema#string

Johannes Grimm

http://www.w3.org/2001/XMLSchema#string

Marion Wobser

http://www.w3.org/2001/XMLSchema#string

Sebastian Haferkamp

http://www.w3.org/2001/XMLSchema#string

Svenja Meierjohann

http://www.w3.org/2001/XMLSchema#string

P2860

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation.

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

P2888

s41389-018-0082-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41389-018-0082-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roland Houben

P577

2018-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30237393

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

molecular biology

P932

6147791

http://www.w3.org/2001/XMLSchema#string